Publications

Research outputs, reports, policy briefs and knowledge products from KIU scholars and partners.

Knowledge Outputs

Featured publications

Publication records can include DOI links, downloads, authors, abstracts and indexing data.

Reset
5,279 results found Records are sourced from the KIU Publications module.
2025 Faculty of Biomedical Sciences

Plant-Derived Alkaloids as Multifunctional Agents in Insulin Resistance, Obesity, and Metabolic Syndrome

Atukunda Derrick

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 99-108

Metabolic syndrome, a cluster of interconnected metabolic disturbances including obesity, insulin resistance, dyslipidemia, and hypertension, represents a major global health challenge. Current therapeutic strategies often target individual components of the...

2025 School of Pharmacy

Neurotoxicity and Reproductive Hormone Dysregulation: Oxidative Stress and Immunomodulatory Mechanisms Across the Gut-Brain-Gonadal Axis

Nakawungu Catherine

2025 | IDOSR JOURNAL OF APPLIED SCIENCES | Pp. 23-28

The gut–brain–gonadal (GBG) axis represents a complex bidirectional network integrating endocrine, neural, and immune signals to regulate homeostasis. Emerging evidence indicates that dysregulation of reproductive hormones, such as estrogens, progesterone, an...

2025 School of Pharmacy

Natural Products Targeting Adipokine Regulation in Obesity-Induced Type 2 Diabetes

Mangen Joshua Fred

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 89-98

Obesity-induced type 2 diabetes (T2D) is a complex metabolic disorder characterized by insulin resistance and chronic low-grade inflammation. Adipokines bioactive peptides secreted by adipose tissue play a pivotal role in modulating glucose homeostasis, lipid...

2025 School of Pharmacy

Natural Product-Derived Modulators of the Gut Microbiota in the Prevention of Obesity-Induced Diabetes

Niwarinda Arnold

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 78-88

The global prevalence of obesity and type 2 diabetes mellitus (T2DM) continues to rise at an alarming rate, posing a major public health and economic challenge worldwide. Growing evidence indicates that the gut microbiota plays a crucial role in the developme...

2025 School of Pharmacy

Natural Product-Based Modulation of Adipokines and Myokines: Implications for Obesity-Driven Diabetes

Niwarinda Arnold

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 70-77

Obesity-driven type 2 diabetes is a multifactorial metabolic disorder in which dysfunctional inter-organ communication particularly between adipose tissue and skeletal muscle plays a pivotal role. Adipokines and myokines are hormone-like factors produced by a...

2025 School of Pharmacy

Narrative Review of Microbiome and Non-Communicable Diseases

Ahereza Prissy

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 59-69

Non-communicable diseases (NCDs), including obesity, diabetes, cardiovascular disease, cancer, and chronic respiratory disorders, are the leading global causes of morbidity and mortality. Recent advances in microbiome research have revealed its central role i...

2025 School of Pharmacy

Narrative Review of Microbiome and Aging

Nabuuma Ruth Nambi

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 48-58

The human microbiome, composed of trillions of bacteria, archaea, fungi, and viruses, is essential for maintaining metabolic, immune, and neurological homeostasis. With aging, the composition and function of microbial communities undergo profound changes, con...

2025 School of Pharmacy

Nanovaccines in Cancer Immunoprevention and Immunotherapy: Current Insights and Future Directions

Ssenkayi Julius

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 39-47

Cancer immunotherapy has emerged as a powerful approach to harness the immune system to combat tumors, while cancer immunoprevention aims to elicit protective immunity before cancer onset. Nanovaccines engineered nanoparticles that deliver tumor-associated an...

2025 Faculty of Clinical Medicine and Dentistry

Nanovaccines and Immunomodulatory Nanoparticles for Preventing Obesity-Induced Diabetes

Serunjogi Ruth

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 31-38

Obesity-induced type 2 diabetes mellitus (T2DM) is a growing global health concern driven by chronic lowgrade inflammation, insulin resistance, and impaired metabolic homeostasis. Conventional therapies such as lifestyle interventions, antidiabetic drugs, and...

2025 Faculty of Clinical Medicine and Dentistry

Nanotechnology-Driven Drug Delivery Systems for Obesity Management

Serunjogi Ruth

2025 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 24-30

Obesity is a growing global epidemic, associated with diabetes, cardiovascular disease, cancer, and diminished life expectancy. Pharmacological treatments are often limited by poor bioavailability, low target specificity, and systemic toxicity. Nanotechnology...